Researchers discover new biomarker to predict multiple sclerosis progression
Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS).
Celebrating 25 years of GOARN’s global health impact
The Global Outbreak Alert and Response Network (GOARN), an initiative coordinated by the World Health Organization (WHO), marks its 25th anniversary today.
As a diversity grant dies, young scientists fear it will haunt their careers
Adelaide Tovar, a University of Michigan scientist who researches genes related to diabetes, used to feel like an impostor in a laboratory. Tovar, 32, grew up poor and was the…
A journey through science, software, and innovation: Insights from the Bruker software team
Follow Bruker's experts as they discuss the SCRUM approach to software development in the scientific industry.
How blood iron levels shape the pace of biological aging
Researchers examine the role of blood iron levels in DNA methylation-based measurements of biological aging.
Pecans lower cholesterol and improve diet quality in at-risk adults, study finds
Substituting 57 grams of pecans for usual snacks over 12 weeks improved lipid profiles and diet quality but did not affect vascular function in adults at cardiometabolic risk. A modest…
Hormone therapy boosts heart health markers but raises some risks
Researchers assess hormone therapy-induced changes in cardiovascular biomarkers.
PET scans reveal early signs of Parkinson’s and Lewy body disorders
In a comprehensive Genomic Press perspective article published today, researchers from Fudan University and Shanghai University of Traditional Chinese Medicine have highlighted remarkable advances in the development of positron emission…
Largest study to date reveals high blood sugar accelerates heart damage in healthy youth
In the present study, 1,595 adolescents drawn from the University of Bristol's Children of the 90s cohort were followed up from age 17 until 24 years. To assess the prevalence…
Routine molecular monitoring doubles survival in high-risk AML subtypes
A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia (AML) by helping doctors identify if they might relapse up…